MedTrace Logo

Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants

NCT01206946 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 700

Last updated 2011-06-23

No results posted yet for this study

Summary

The hypothesis of the study is that administration of antenatal steroid to women at high risk of preterm birth after 34 weeks of gestation would reduce the risk of respiratory complications, specifically Respiratory Distress Syndrome (RDS) or Transient Tachypnea of the Newborn (TTN) in late preterm babies.

Conditions

  • Respiratory Distress Syndrome, Newborn
  • Transient Tachypnea of the Newborn

Interventions

DRUG

Betamethasone

A single course of betamethasone (two doses of 12 mg/dose given at 24 hourly intervals)

OTHER

Normal Saline

Two doses of 2ml of normal saline given at 24 hourly intervals

Sponsors & Collaborators

  • American University of Beirut Medical Center

    lead OTHER

Principal Investigators

  • Khalid Yunis, MD · American University of Beirut Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01206946 on ClinicalTrials.gov